A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma

Conditions:   Lymphoma;   DLBCL;   T Cell Lymphoma Intervention:   Drug: Selinexor Sponsor:   Ruijin Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials